Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
By Product Status:
By Molecule:
By Species:
By Tag:
By Conjugate:
Kits(1) Hot Products: Multi-pass transmembrane proteins GMP grade products
Cat. No. Product Description Size&Price Compare
EBS-002 ELISA Buffer Set (Phosphate system, 96T)
Beads(2) Hot Products: Multi-pass transmembrane proteins GMP grade products
Cat. No. Product Description Size&Price Compare
MB-01 Magnetic Stand for 4 Tubes (15mL, 50mL)
MB-02 Magnetic Stand for 12 Tubes (1.5mL, 2mL)
Plate(2) Hot Products: Multi-pass transmembrane proteins GMP grade products
Cat. No. Product Description Size&Price Compare
FCM-C03M Magnetic Capture Plate
FCM-B01M 96-Well Filter Plate
Cell(1) Hot Products: Multi-pass transmembrane proteins GMP grade products
Cat. No. Product Description Size&Price Compare
CHEK-SP01 HEK293 Cell Line
Buffer(2) Hot Products: Multi-pass transmembrane proteins GMP grade products
Cat. No. Product Description Size&Price Compare
DB-02 Dilution Buffer (Strengthen Blocking)
DC-11 200x DDM CHS buffer
Licensing(19) Hot Products: Multi-pass transmembrane proteins GMP grade products
Target Project item Indications Research phase Cooperation demands
- BHE202220 NASH IND, IP has been granted in the US, CN, etc License-out or co-development the global right
- BJM202301 Hematological malignancy and Solid tumors IND-approved License-out or co-development
- BNO202203 IBD, expanded indication COVID-19 IND ready License-out or co-development
- BDB202301 Glioblastoma Ready to start phase 1 (improved variant of Temodex®) license-out or co-development Globally except in CIA
- BDA202205 bacterial infections caused by specific microbial sensitive strains, such as complex or non-complex skin and skin soft tissue infections, community/hospital acquired pneumonia, vancomycin-resistant enterococcal infections, other bone and joint infections, IND License-out or co-development the global right
- NSS21001 Cancer Cachexia Preclinical License-out or co-development the global right
- BHE202218 CKD and Renal anemia Phase 1 License-out or co-development of the global right (except for China)
- BHE202219 Idiopathic pulmonary fibrosis (IPF) and solid tumor, (FDA ODD) Phase 1 License-out or co-development
- BHE202217 Migraine Phase 1 License-out or co-development
- BHE202207 HBV Phase 3 China, Phase 2, US License-out or co-development
- BHE202211 Hematologic malignancies Phase I, China; the patent has been granted in the US License-out and co-development
- BHE202216 HBV Phase 1 License-out or co-development
- BHE202202 NSCLC, Medullary thyroid cancer, Thyroid cancer Phase 1 License-out or co-development
- BHE202206 Depression Phase II/ III License-out or co-development
- BHE202213 Pulmonary arterial hypertension (PAH), Chronic thromboembolic pulmonary hypertension (CTEPH), Heart failure with reduced ejection fraction (HFrEF), Chronic kidney disease (CKD) Phase 1, IP has been granted in US, AU, CN License-out or co-development
- BHE202203 Hyperuricemia (HUA) Phase 1 is ongoing in China License-out or co-development
- BHE202205 NASH Phase I is finished in AU/Phase II is ongoing in CN License-out or co-development
- BHE202208 Diabetes Phase III Out licensing global right
- BHE202214 Diabetic kidney disease Phase I is ongoing in China Out licensing global right
Total:27
1
Results Per Page

Development Suggestion

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message